The efficacy of adalimumab therapy in refractory hidradenitis suppurativa: Retrospective analysis
Journal Title: Türkderm - Deri Hastalıkları ve Frengi Arşivi - Year 2019, Vol 53, Issue 3
Abstract
Background and Design: Hidradenitis suppurativa (HS) is a painful, chronic, inflammatory skin disease and there is no effective standard method for its treatment. The studies on the successful results of adalimumab in the treatment of HS are increasing and its use is approved by the Ministry of Health in our country. Materials and Methods: The efficacy and side effects of adalimumab were evaluated retrospectively in 9 patients who were diagnosed with resistant HS. Adalimumab was administered 40 mg subcutaneously per week. Patients were followed closely for infections and other side effects. In patients, nodules, abscesses and fistulas were determined at the beginning of the treatment, at the 4th and 12th week of the treatment. The values of global pain scores, life quality index scores and C-reactive protein (CRP) levels recorded at the beginning and at the 12th week of the treatment were evaluated. Results: The ages of 9 patients receiving adalimumab for severe HS were between 33-67 (mean: 50.6), and 7 of the patients were male. The disease duration ranged from 2 to 25 years (mean: 13 years) 5 of the patients according to the Hurley classification was determined as stage 2 and 4 as stage 3. In the 12th week, the number of nodules, abscess and draining fistulas were decreased respectively 60.2%, 69.3% and 52.1%. C-reactive protein levels CRP of 16.3 mg/L at the beginning of treatment were 5.5 mg/L at 12 weeks. Before the treatment, life quality index score was 23.4, and after 12 weeks, the score decreased to 6.8. There was a significant improvement in the quality of life. Pain scores of 6.6±3.4 before the treatment were reduced to 1.5±2.5 in the 12th week of treatment. No side effects were observed during treatment. Coclusion: In this study, adalimumab was evaluated as an effective and well tolerated treatment option in moderate and severe HS.
Authors and Affiliations
Meltem Türkmen
Keywords
Related Articles
- EP ID EP657161
- DOI 10.4274/turkderm.galenos.2019.58295
- Views 117
- Downloads 0
ABO Blood Types and Risk of Testicular Cancer in Turkish Population: Preliminary Results
Objective: ABO blood type has been reported to be associated with various types of cancer such as lung cancer, prostate cancer, bladder cancer and pancreatic adenocarcinoma. We aimed to determine whether there is a relat...
Lichen striatus occurring after a tetanus vaccine: A case report
Lichen striatus (LS) is an uncommon, acquired, self-limiting, linear inflammatory dermatosis. The eruption typically presents as pink or tan papules along Blaschko’s lines. It usually occurs in children, rarely affects a...
The role of thiol/disulfide homeostasis in psoriasis: Can it be a new marker for inflammation?
Background and Design: Psoriasis vulgaris is a chronic, systemic, inflammatory disease presenting with oxidative stress and tissue inflammation. Thiol and disulfide levels have been shown to increase in inflammatory dise...
The role of uric acid in metabolic syndrome in patients with psoriasis
Background and Design: Psoriasis patients have increased risk of obesity, metabolic syndrome and cardiovascular disease. Uric acid is a metabolic marker associated with metabolic syndrome and cardiovascular diseases. Uri...
A case of linear syringocystadenoma papilliferum of the axilla: A rare location
.